LXA4 has been shown to restore oxidative stress-induced vascular endothelial cell injury by activating the Nrf2-HO-1 axis, thereby offering a promising strategy for managing venous thromboembolism and its complications [42]. Here, NFE2L2 is linked to venous thromboembolism.